Answer
The safety and efficacy of aprocitentan in children and adolescents under 18 years have not been established, and no data are available.
Sources for this answer
- JERAYGO 12.5 mg film-coated tabletsIdorsia Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked